The historical rank and industry rank for OrbusNeich Medical Group Holdings's Days Payable or its related term are showing as below:
FRA:Q8T'
s Days Payable Range Over the Past 10 Years
Min: 18.25 Med: 34.16 Max: 42.94
Current: 35.14
During the past 7 years, OrbusNeich Medical Group Holdings's highest Days Payable was 42.94. The lowest was 18.25. And the median was 34.16.
FRA:Q8T's Days Payable is ranked worse than 79.75% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:Q8T: 35.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings Days Payable Chart
FRA:Q8T vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's Days Payable falls into.
OrbusNeich Medical Group Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Days Payable of 30.13 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 12% below median its historical median of 34.16. Over the past decade, OrbusNeich Medical Group Holdings' Days Payable has ranged from 18.25 to 42.94. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #634 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 79.7%.
Is OrbusNeich Medical Group Holdings' Days Payable too high?
OrbusNeich Medical Group Holdings' current Days Payable of 30.13 is 12% below median its 10-year median of 34.16. Over the past 10 years, this metric has ranged from a low of 18.25 to a high of 42.94. The Medical Devices & Instruments industry median Days Payable is 68.07. OrbusNeich Medical Group Holdings' value of 30.13 is 55.7% below this industry median. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #634 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #634 out of 795 companies for Days Payable. This places OrbusNeich Medical Group Holdings in the lower half of its industry. The industry median Days Payable is 68.07. OrbusNeich Medical Group Holdings' value of 30.13 is 55.7% below this benchmark. Historically, OrbusNeich Medical Group Holdings' own Days Payable has ranged from 18.25 to 42.94 over the past decade. While the company's 10-year median is 34.16 vs. the industry median of 68.07, OrbusNeich Medical Group Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrbusNeich Medical Group Holdings's current Days Payable of 30.13 is 55.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OrbusNeich Medical Group Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrbusNeich Medical Group Holdings's current Days Payable is 30.13, which is 12% below median its own 10-year median of 34.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Days Payable of 30.13. The stock's GF Value™ is €0.48, compared to a current price of €0.37 — trading 22.5% below its estimated fair value. The current Days Payable is 30.13, which is 12% below median its 10-year median of 34.16 and 55.7% below the Medical Devices & Instruments industry median of 68.07. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Days Payable is 30.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.37 is trading 22.5% below its estimated GF Value™ of €0.48.
Key valuation signals for FRA:Q8T:
Days Payable: 30.13 (12% below median its 10-year median of 34.16)
GF Value™: €0.48 vs. price of €0.37 (22.5% below fair value)
Industry Position: 55.7% below the Medical Devices & Instruments median (#634 of 795)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score
Get the complete analysis for FRA:Q8T
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
